Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study

NCT04306939 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT04306939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04306939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Suspended
Start date
November 1, 2014
Completion date
December 31, 2026
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatitis, bile acid synthesis defect, biliary cirrhosis, celiac disease, cholecystitis, cholelithiases, chronic disease, chronic kidney diseases, chronic pain, chronic pancreatitis, constipation - functional, constipation chronic idiopathic, crohn disease, cyst pancreas, cystic fibrosis, diabetes mellitus, diarrhea chronic, dyslipidemias, gastritis, hepatitis, inflammatory bowel diseases, ipmn, irritable bowel syndrome, multiple sclerosis, nash - nonalcoholic steatohepatitis, pancreatic exocrine insufficiency, rheumatoid arthritis